Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/1996
03/13/1996EP0521974B1 Veterinary treatment
03/13/1996EP0500823B1 Antimalarial compositions
03/13/1996EP0439513B1 Composition for inhibiting transmission of aids
03/13/1996EP0436545B1 Therapeutic methods using catalytic antibodies
03/13/1996CN1118571A Bisacodyl dosage form
03/13/1996CN1118352A New steroids containing in position 20 an aminosubstitued chain, preparation procass and intermediates of this process, use as medicaments and pharmaceutical compositions containing them
03/13/1996CN1031266C Process for preparation of heterocycle ether derivatives
03/13/1996CN1031262C Ring-substituted 2-animo-1,2,3,4-tetra hydronaphthalenes and 3-aminochromanes
03/13/1996CA2157998A1 Pharmaceutical compounds
03/13/1996CA2157849A1 Injectable liposomal pharmaceutical preparations
03/12/1996US5498788 Inclusion complexes of clavulanic acid and of potassium salts thereof with hydrophobic β-cyclodextrin derivatives a process for the preparation thereof
03/12/1996US5498775 Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation
03/12/1996US5498745 Antiallergen intermediates, inhibitors of leukotrienes, lipoxygenase inhibitors
03/12/1996US5498728 Osteoporosis
03/12/1996US5498722 Hypotensives
03/12/1996US5498618 4-amino-N-(4-methyl-4-piperidinyl)-2-methoxybenzamides for treating smooth muscle contraction disorders
03/12/1996US5498617 Bone disorders
03/12/1996US5498616 Cysteine protease and serine protease inhibitors
03/12/1996US5498608 Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
03/12/1996US5498423 Method for correcting plasma melatonin levels and pharmaceutical formulation comprising melatonin
03/12/1996CA2016182C Heterocyclicguanidines as 5ht- antagonists
03/12/1996CA1338163C Process for the preparation of n-alkylated dipeptides and their esters
03/12/1996CA1338162C Process for the preparation of n-alkylated dipeptides and their esters
03/07/1996WO1996007096A1 AN IN VITRO SYSTEM FOR DETERMINING FORMATION OF Aβ AMYLOID
03/07/1996WO1996006943A1 Cell cycle regulated repressor and dna element
03/07/1996WO1996006940A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
03/07/1996WO1996006939A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
03/07/1996WO1996006937A1 Improvements in production of proteins in host cells
03/07/1996WO1996006863A1 Agents for inducing apoptosis and applications of said agents in therapy
03/07/1996WO1996006842A1 Salts of an anti-migraine indole derivative
03/07/1996WO1996006841A1 Quinazoline derivative
03/07/1996WO1996006840A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
03/07/1996WO1996006821A1 Neurotrophic and antiproliferative compounds
03/07/1996WO1996006640A1 Bioadhesive-wound healing composition
03/07/1996WO1996006635A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound
03/07/1996WO1996006620A2 Lipid analogs for treating viral infections
03/07/1996WO1996006616A1 Quinazolinone pharmaceuticals and use thereof
03/07/1996WO1996006609A1 Inhibitors of farnesyl-protein transferase
03/07/1996WO1996006605A1 Method of reducing body fat in animals by the administration of conjugated linoleic acid
03/07/1996WO1996006604A2 Methods for identifying and treating resistant tumors
03/07/1996WO1996003515A3 Surface expression of enzyme in gene directed prodrug therapy
03/07/1996CA2198752A1 Methods for identifying and treating resistant tumors
03/07/1996CA2198728A1 Neurotrophic and antiproliferative compounds
03/07/1996CA2198726A1 Inhibitors of farnesyl-protein transferase
03/07/1996CA2198721A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound
03/07/1996CA2198474A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
03/07/1996CA2198473A1 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
03/07/1996CA2198472A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
03/07/1996CA2198345A1 Improvements in production of proteins in host cells
03/07/1996CA2198080A1 Cell cycle regulated repressor and dna element
03/07/1996CA2197895A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
03/07/1996CA2194876A1 Bioadhesive-wound healing composition
03/06/1996EP0699753A2 Protein for the transport of cationic xenobiotic and/or pharmaceutical compounds, DNA sequences coding therefore and its uses
03/06/1996EP0699678A1 Crystalline form of dihydro-2,3-benzodiazepine derivative
03/06/1996EP0699676A1 Physical form of dihidro-2,3-benzodiazepine derivative
03/06/1996EP0699674A1 1-Aryl-2-acetylamidopentanone derivatives for use as tachykinin receptor antagonists
03/06/1996EP0699673A1 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
03/06/1996EP0699672A1 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
03/06/1996EP0699666A1 Heterocyclic substituted benzoylguanidine
03/06/1996EP0699665A1 Imidazoline derivatives, their preparation and their use as tachykinin receptor antagonists
03/06/1996EP0699442A1 Use of a strain of the fungus fusarium as a substance producer and a preparation based onit with adaptogenic and immunomodulating properties
03/06/1996EP0699439A2 Treatment of diseases caused by sebaceous gland disorders with acyl CoA cholesterol acyl transferase inhibitors
03/06/1996EP0699438A2 Use of neurotensin antagonists for the preparation of diuretic drugs
03/06/1996EP0699429A2 Method of promoting hair growth
03/06/1996EP0699428A1 Cosmetic or dermatological composition comprising encapsulated extracts of cornflour
03/06/1996EP0699204A1 Use of indolocarbazole derivatives to treat a pathological condition of the prostate
03/06/1996EP0699194A1 5-ht4 receptor antagonists
03/06/1996EP0699192A1 Substituted oxazolyl compounds for the treatment of inflammation
03/06/1996EP0699191A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
03/06/1996EP0699188A1 Quinoline derivatives as leukotriene antagonists
03/06/1996EP0699186A1 Indole derivatives as antagonists of excitatory amino acids
03/06/1996EP0699182A1 Cyclopropylacetonitrile derivatives, preparation thereof and use thereof as drugs
03/06/1996EP0699074A1 Thrombin inhibitors
03/06/1996EP0587723B1 Quinuclidine derivatives
03/06/1996EP0571471B1 5-heteroyl indole derivatives
03/06/1996EP0528949B1 An apparatus for preparing a concentrate of coagulation factors, such as fibrinogen, from a blood sample
03/06/1996EP0362259B1 Method of producing cystatin c or modifications hereof and dna-sequence for use when carrying out the method
03/06/1996CN1118160A Polyamine derivatives as radioprotective agents
03/06/1996CN1117965A Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines
03/06/1996CN1117960A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
03/06/1996CN1117874A Nasally administrable compositions
03/06/1996CN1117872A Health-care medicinal liquor
03/06/1996CN1117867A Medicine for prevention and treatment of iodine-deficient disease and preparation method thereof
03/06/1996CN1117864A "Zaishengwan" - a Chinese proprietary medicine for treatment of hemiplegia
03/06/1996CN1031193C Polypeptide and method for preparing same
03/05/1996US5496801 Storage stability, mannitol, citric acid buffer
03/05/1996US5496558 Solid form xerostomia product
03/05/1996US5496556 Administering a steroid reductase inhibiting compound, an androstene derivative
03/05/1996CA2085733C Polycyclic guanine derivatives
03/05/1996CA1338109C Pyridine derivatives and intermediates thereof
03/02/1996CA2157231A1 Oxa- or thia-aliphatically bridged quinoxaline-2,3-diones
03/01/1996CA2157236A1 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
03/01/1996CA2157235A1 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
02/1996
02/29/1996WO1996006188A1 Peptide librairies as a source of syngenes
02/29/1996WO1996006169A1 Human chemokine beta-9
02/29/1996WO1996006114A1 Cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells
02/29/1996WO1996006098A1 Spiro-azabicyclic compounds useful in therapy
02/29/1996WO1996006095A1 Endothelin antagonists
02/29/1996WO1996006094A1 Novel substituted piperidines useful for the treatment of allergic diseases
02/29/1996WO1996006083A1 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists
1 ... 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 ... 1564